The optimal choice of technique for the surgical treatment of pancreatic head lesions in chronic pancreatitis is still under debate. This systematic review and meta-analysis aims to compare the effectiveness and safety of duodenum-preserving pancreatic head resection (DPPHR) versus pancreatoduodenectomy (PD) by means of parameters of mortality and morbidity and functional outcomes and quality of life. Methods: A systematic literature search (Medline, Embase, Biosis, The Cochrane Library, and Science Citation Index) was performed to identify randomized controlled trials (RCTs) comparing DPPHR and PD. Included literature was assessed and extracted by 2 independent reviewers. A meta-analysis of pain relief (primary end point), several parameters of short-and long-term measures and quality of life, was done using the random effects-model. Results: In total, 1284 citations were checked for eligibility and 4 RCTs were included. The critical appraisal revealed a heterogeneous methodological quality of included trials. Comparing DPPHR versus PD, postoperative pain relief, overall mortality, and morbidity showed no significant difference. Intraoperative blood replacement, hospital stay, weight gain, exocrine insufficiency, occupational rehabilitation, and quality of life were significantly improved in the DPPHR group. Conclusion: DPPHR and PD seem to be equally effective in terms of postoperative pain relief, overall morbidity, and incidence of postoperative endocrine insufficiency. However, the presented findings suggest superiority of DPPHR in the treatment of chronic pancreatitis with regard to several peri and postoperative outcome parameters and quality of life. Further RCTs are eagerly awaited to prove these findings. (Ann Surg 2008;247: 950 -961) C hronic pancreatitis is defined as a continuous inflammatory process causing permanent structural damage to the pancreatic gland, which ultimately results in impairment of the gland's exocrine and endocrine function.
C
hronic pancreatitis is defined as a continuous inflammatory process causing permanent structural damage to the pancreatic gland, which ultimately results in impairment of the gland's exocrine and endocrine function. 1, 2 A recently published randomized controlled trial (RCT) demonstrated surgical treatment (drainage by pancreaticojejunostomy by the method of Partington-Rochelle) as being superior compared with endoscopic drainage in patients with chronic pancreatitis and a distal pancreatic duct obstruction without an inflammatory mass. 3 Patients with chronic pancreatitis who present with inflammatory pancreatic head enlargement commonly require pancreatic head resection because of the development of local complications (eg, stenosis of the common bile duct and/or main pancreatic duct, duodenal obstruction, compression of retropancreatic vessels), to the suspicion of malignancy, and most commonly to intractable pain. 4, 5 Pancreatoduodenectomy (PD), namely the conventional and the pylorus-preserving PD have served for many years as the primary surgical procedures. However, PD is reported as being unsatisfactory in terms of late morbidity with a high incidence (up to 48%) of postoperative diabetes mellitus. 6 This is attributed to its extensive resection including the removal of the duodenum and a large portion of the pancreas. To preserve the duodenum and limit resection of the pancreatic tissue to a minimum, the duodenum-preserving pancreatic head resection (DPPHR) was introduced by Beger in 1972. 7, 8 Although the Beger procedure selectively removes the pancreatic head, 7 several modifications were developed to prevent dissection of the pancreas above the portal and superior mesenteric veins, which is a potential source of hemorrhage particularly in the case of portal hypertension. The Frey procedure, consists of a local resection of the pancreatic head which is combined with lateral pancreaticojejunostomy. 5 , 9 Gloor et al 10 described another modification, where the pancreatic head is resected subtotally leaving a narrow layer of pancreatic tissue toward the duodenum and the retropancreatic vessels.
Although several narrative reviews have already discussed potential superiority of the DPPHR, 11, 12 no systematic and quantitative review summarizing the available evidence has been conducted to date. Therefore, the objective of this systematic review and meta-analysis was to assess the existing evidence of currently used surgical procedures for chronic pancreatitis to compare the effectiveness and safety of DPPHR techniques versus PD.
METHODS
A written study protocol was developed before the conduct of the systematic review. The objective, inclusion, and exclusion criteria, outcome parameters, and methods for analysis were predefined.
Systematic Literature Search
A systematic literature search was conducted independently by 2 authors (M.K.D., N.N.R.) using validated methods of the Cochrane Collaboration. 13, 14 The search strategy in Medline (PubMed) was based on combinations of Medical Subject Heading terms and text words and was not restricted to specific languages or years of publication. The last search was carried out on December 20, 2006 . The detailed search algorithm for the Medline search (PubMed) is presented in Table 1 .
Searched 
Study Selection
All stages of study selection, data abstractions, and quality assessment were done independently by 2 reviewers (M.K.D., N.N.R.). Search findings were screened for potentially eligible studies. Abstracts and full articles were obtained for detailed evaluation and eligible trials were included into the systematic review. Any disagreements during the selection, extraction, and assessment process were resolved by discussion with a third author (C.M.S.).
Eligibility Criteria
Peer-reviewed publications of studies that met the following criteria were eligible for inclusion: (1) RCTs comparing DPPHR (Beger, Frey, and modifications) with PD (conventional or pylorus-preserving PD); (2) the study population consisted of patients diagnosed with chronic pancreatitis who planned elective surgery. Studies that presented insufficient data regarding our prespecified outcome parameters, pediatric trials, and studies comparing endoscopic or laparoscopic techniques alone or against each other were excluded from our analysis.
Data Extraction and Quality Assessment Outcome Measures
The following parameters were extracted on standardized forms:
Primary outcome parameters: relief of abdominal pain. Quantification of pain relief has to be based either on validated and comparable reliable methods (eg, visual analogue scale) or on ratios of pain-free patients postoperatively.
Secondary outcome parameters: If a study generated multiple publications, the most comprehensive and current report was used for data abstraction for the meta-analysis. Additional publications were used to assess potential supplementary information (eg, baseline characteristics of the patients, descriptions of the surgical techniques).
According to international recommendations, 15,16 the methodological quality of included studies was assessed using a standardized form to extract prespecified parameters. 17, 18 Thus, the critical appraisal of extracted data included rating of the randomization procedure, allocation concealment, sample size calculation, consistency of the study population, length, and quality of follow-up, rate of patients lost to follow-up, and statistical analysis of individual trials. The full extraction sheet is available on request. Reporting was in accordance with the QUOROM Statement.
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Statistical Analysis
The synchronized extraction results were pooled as estimates of overall treatment effects in a meta-analysis and 13 The weight of each study was related to its sample size. All results were investigated for clinical and statistical heterogeneity. Clinical heterogeneity was defined as the existence of an inhomogeneous study population, the variability of interventions, and the insufficient definition of outcome parameters or major variability in perioperative management. Clinical heterogeneity was explained when appropriate and possible. Statistical heterogeneity was explored by inspection of the forest plot and I 2 statistic. 20 To account for clinical heterogeneity (varying or missing definitions of outcome parameters), overall estimates were calculated using the random effects models (Review Manager, Version 4.2 for Windows, The Cochrane Collaboration, 2003). 21 The results of the meta-analysis are therefore presented as more conservative estimates than an analysis with a fixed effect model in absence of clinical heterogeneity would generate. 22 -statistics were used to measure chance-corrected agreement of study selection by the 2 reviewers (SPSS for Windows Version 11.5.1, SPSS, Chicago, IL). 23 Power calculations were done using the methods described by DeMets and coworkers. 24 Data are presented as Forest plots. The vertical line represents the line of equivalence between the methods being compared (ie, relative risk ϭ 1). Individual trials are presented horizontally; the squares for each trial represent the point estimate with the area of the square being proportional to the amount of information (ie, sample size) and the line represents the 95% CI. Summary measures are presented by diamonds, where the width of the diamond corresponds to the 95% CI. Two-sided P-values were used throughout. Figure 1 shows a flow diagram according to the QUOROM-statement 19 with the total number of citations retrieved by the search strategy and the number included in the systematic review. The systematic literature search initially identified 1284 potential titles and abstracts; of these, 1061 irrelevant citations were excluded and the remaining 223 references were retrieved as full text articles for further assessment. A further 213 had to be excluded because of nonrandomized study design or not meeting inclusion criteria (eg, not referring to surgical treatment of chronic pancreatitis).
RESULTS
Description of Studies
Chance-corrected agreement (-statistics) showed substantial conformity between the 2 reviewers at all steps of study selection (step 1: ϭ 0.89; step 2: ϭ 0.95; step 3: ϭ 1.0). In total, 10 publications were assessed in detail. Four trials [25] [26] [27] [28] fulfilled the criteria for inclusion in the systematic review and meta-analysis. Four publications provided additional information of already included trials and were therefore excluded. 29 -32 One trial was not eligible because of comparison of 2 DPPHR procedures (Frey vs.
Beger 33 ). The trial by Makowiec et al 34 had to be excluded because this trial was not published in a peer-reviewed journal yet. Scanning the identified trials did not reveal any additional relevant references. All authors were contacted for additional information and 3 of them replied. [25] [26] [27] Included trials were published between 1995 25,27 and 2006. 26 Three of these trials were conducted in Germany 25, 27, 28 and 1 in Hungary. 26 A total of 200 randomized participants were included and the sample size ranged from 43 27 to 64 28 randomized patients. The percentage of included females ranged from 10% 25 to 25% 26 and the mean age of the study patients ranged from 43 years 25, 26, 28 to 47 years. 27 Indication for operation was abdominal pain (91% DPPHR; 95% PD), [25] [26] [27] [28] pancreatic head enlargement (100% DPPHR; 100% PD), 25, 26, 28 duodenal obstruction (15% DPPHR; 12% PD), [25] [26] [27] [28] and bile duct stenosis (35% DPPHR; 34% PD). [25] [26] [27] [28] The trial by Büchler et al 25 compared the Beger procedure with the pylorus-preserving PD. This trial consisted of FIGURE 1. Number of abstracts and articles identified and evaluated during the review process. Modified flow chart according to QUOROM. 19 -statistics indicates chance corrected observer variability: a of 0.8 to 1.0 stands for almost perfect agreement beyond chance. 23 
Diener et al
Study Quality
Heterogeneous study quality was observed in terms of sample size, allocation concealment, standardization of study interventions, definition of outcome parameters, consistency of follow-up, and blinded outcome assessment. Three studies presented descriptions of prospective sample size calculations, 25, 26, 28 whereas detailed justification of the applied sample sizes lacked in all cases.
The randomization process was described adequately in 1 study 28 ; 3 authors detailed the randomization process on request. [25] [26] [27] Although 3 studies provided information on timing of randomization, 25, 26, 28 there were only 2 trials 27, 28 with further information regarding allocation concealment.
None of the studies included in the meta-analysis reported blinded outcome assessment. In contrast to the RCT of Farkas et al, 26 outcome parameters were adequately defined in the remaining 3 studies.
Two studies prospectively applied predefined follow-up dates at 6 months 25 and 12 months 26 after surgery, respectively. In the remaining studies, duration of follow-up varied among patients. None of the studies were reported according to the CONSORT guidelines. 35 
Outcome Parameters Pain Relief
All 4 trials assessed and reported on the primary end point. Overall, the data of 173 patients were suitable for meta-analysis. The comparison of DPPHR versus PD in terms of postoperative pain relief showed no significant difference (RR 1.08; 95% CI, 0.88 -1.33; P ϭ 0.46; I 2 ϭ 43% data heterogeneity) ( Table 2 ; Fig. 2 ). There was an absolute risk reduction of 9.5% (95% CI, Ϫ2% to 22%) for postoperative pain by performing the DPPHR. Accordingly, the number needed to treat to achieve one additional pain free patient was 10 (DPPHR vs. PD: 95% CI, 4 -36).
Mortality, Morbidity, and Perioperative Clinical Outcome Parameters
In total, 2 of 184 analyzed patients died (1%). Mortality rate for PD was 0% and 0% to 4.55% for DPPHR (Table 3) .
Overall postoperative morbidity was highest in the PD group of Izbicki et al 28 (53%), whereas a morbidity of only 18% was observed in the DPPHR group in the trial by Klempa et al. 27 Comparing the DPPHR and the PD in terms of overall morbidity no difference of either strategy was observed (RR 0.54; 95% CI, 0.20 -1.46; P ϭ 0.22; I 2 ϭ 73.8% data heterogeneity) ( Table 2 ; Fig. 3 ).
Neither the analysis of individual trials nor the metaanalysis of all DPPHR versus PD revealed any significant difference regarding postoperative pancreatic fistula development (RR 0.39; 95% CI, 0.08 -1.97; P ϭ 0.26; I 2 ϭ 0% data 
Annals of Surgery
Surgical Treatment of Chronic Pancreatitis heterogeneity). Delayed gastric emptying showed a trend in favor of the DPPHR group (RR 0.23; 95% CI, 0.05-1.11; P ϭ 0.07; I 2 ϭ 32% data heterogeneity). Exclusive analysis of the trials comparing the Frey procedure versus pyloruspreserving PD 26, 28 showed a significant reduction of delayed gastric emptying (RR 0.06; 95% CI, 0.01-0.46; P Ͻ 0.01; I 2 ϭ 32% data heterogeneity) ( Table 2) .
Perioperative parameters could not demonstrate significant difference of median operating time (minute) comparing the DPPHR with PD (WMD Ϫ53.03 minutes; 95% CI, Ϫ134.96 to 28.89; P ϭ 0.20; I 2 ϭ 99.2% data heterogeneity). However, the Frey procedures versus pylorus-preserving PD showed significant reduction of operating time in favor of the DPPHR procedures (WMD Ϫ112.45 minutes; 95% CI, Ϫ164.07 to Ϫ60.84; P Ͻ 0.01; I 2 ϭ 88.6% data heterogeneity). Besides the trial of Büchler et al 25 with a hemorrhage rate of 10% for the Beger and 0% for the pylorus-preserving PD procedure, the remaining trials reported similar or less hemorrhage in the DPPHR: Beger versus pylorus-preserving PD (0% vs. 2.3%); Frey versus pylorus-preserving PD (0%-3.2% vs. 0%-6.7%); Beger versus PD (4.5% vs. 9.5%) ( Table 3) . Accordingly, the need for perioperative blood replacement was significantly lower for the DPPHR procedures compared with PD (WMD Ϫ1.28 units; 95% CI, Ϫ2.32 to Ϫ0.25; P ϭ 0.02; I 2 ϭ 88.7% data heterogeneity) (Fig. 4) . A sensitivity analysis of the Frey versus the pylorus-preserving PD increased the effect size for blood replacement and removed statistical heterogeneity (WMD Ϫ2.09 units; 95% CI, Ϫ2.30 to Ϫ1.87; P Ͻ 0.01; I 2 ϭ 0% data heterogeneity). 26, 28 The analysis of duration of hospital stay (days) showed a significant mean reduction of 4.23 days in the DPPHR group (WMD Ϫ4.23; 95% CI, Ϫ6.46 to Ϫ2.00; P Ͻ 0.01; I 2 ϭ 60.7% data heterogeneity) (Fig. 5) . The trial by Büchler et al 25 did not show any difference in terms of hospital stay comparing the Beger procedure to pyloruspreserving PD. This is in contrast to the results of the trials by Klempa 27 and Farkas, 26 which revealed a significant reduction of hospital stay in the DPPHR group. Consequently, there was an increased reduction of hospital stay and complete removal of statistical heterogeneity by excluding the trial of Büchler et al 25 in the sensitivity analysis (WMD Ϫ5.26; 95% CI, Ϫ6.67 to Ϫ3.86; P Ͻ 0.01; I 2 ϭ 0% data heterogeneity). Izbicki et al 28 did not provide data of hospital stay.
Function and Quality of Life
Assessment of new onset of postoperative diabetes mellitus showed a trend in favor of the DPPHR (RR 0.49; 95% CI, 0.22-1.09; P ϭ 0.08; I 2 ϭ 0% data heterogeneity) ( Table 2 ). Pancreatic exocrine function impairment was significantly reduced in the DPPHR group compared with the PD (RR 0.20; 95% CI, 0.06 -0.66; P Ͻ 0.01; I 2 ϭ 57.7% data heterogeneity) (Fig. 6) . In terms of postoperative weight gain, a significant superiority of the DPPHR could be detected (RR 1.93; 95% CI, 1.33-2.81; P Ͻ 0.01; I 2 ϭ 46.1% data heterogeneity) (Fig. 7) . The analysis of postoperative occupational rehabilitation of included study patients showed a statistically significant increase of postoperative occupational rehabilitation in favor of the DPPHR (RR 1.36; 95% CI, 1.07-1.71; P ϭ 0.01; I 2 ϭ 0% data heterogeneity) (Fig. 8 ). Two trials provided data for the analysis of global quality of life. Izbicki et al 28 applied the validated EORTC score, 36 whereas Farkas et al 26 did not specify their instruments. The meta-analytic pooling exposed a significantly higher global quality of life in the DPPHR group (WMD 25.07; 95% CI, 18.83-31.31; P Ͻ 0.01; I 2 ϭ 57.1% data heterogeneity) (Fig. 9) .
Power Calculation
A power calculation was performed for the primary outcome of pain relief. Our meta-analysis revealed an overall rate of 0.82 for the DPPHR group and 0.72 for the PD group for complete pain relief. To rule out a 10% absolute risk reduction (from 0.72 to 0.82) with a 5% significance level and 80% power, a RCT would require an approximate total sample size of 558 study patients (279 in each arm).
DISCUSSION
Relief of intractable pain and decompression of adjacent organs are the main goals of surgery for chronic pancreatitis. 37 A recent RCT showed pancreatojejunostomy by the method of Partington-Rochelle to be more effective in reducing pain when compared with endoscopic drainage for chronic pancreatitis in patients without inflammatory masses. For pancreatic head enlargement, PD (either conventional or pylorus-preserving PD) has served as the standard surgical treatment for many years. The introduction of DPPHR techniques, however, has led to controversial discussions concerning the optimal surgical management, particularly in regarding the possible improvement in functional outcome, perioperative morbidity, and quality of life. 11, 12, 38 The results of the present systematic review showed no difference for the selected main outcome measure postoperative pain relief. Thus, given both strategies being equally effective in terms of pain relief (RR 1.08; P ϭ 0.46), our findings support the notion of the pancreatic head playing a significant role in pain development and maintenance of patients with chronic pancreatitis because all analyzed techniques resect the pancreatic head, though to varying degrees. 12, 37 Moreover, no differences for mortality and overall morbidity were detected.
However, the inclusion and analysis of 4 RCTs provides evidence for DPPHR (Beger, Frey procedures and modifications) to be superior when compared with PD [25] [26] [27] [28] . Analysis of perioperative parameters and postoperative morbidity revealed reduced operation times (WMD Ϫ53.03 minutes; P ϭ 0.20) and less need for blood replacement for the DPPHR group (WMD Ϫ1.28 units; P ϭ 0.02). In both cases this effect was increased analyzing the 2 trials comparing the Frey and the pylorus-preserving PD separately (operation time Ϫ112.45 minutes; P ϭ 0.01; blood replacement Ϫ2.09 units; P ϭ 0.01).
Further analysis of clinical outcome parameters revealed no significant difference in the postoperative incidence of pancreatic fistula (RR 0.39; P ϭ 0.26) between DPPHR and PD. Delayed gastric emptying has been attributed particularly to pylorus-preserving PD. 39, 40 However, this observation was disproved by a recent systematic review on the comparison of the pylorus-preserving PD versus conventional PD for treatment of pancreatic and periampullary cancer. 41 Accordingly, 3 of the 4 analyzed trials in the present systematic review failed to show significantly higher rate of delayed gastric emptying after PD when compared with the DPPHR techniques. [25] [26] [27] Only the RCT of Izbicki et al 28 showed a significantly higher incidence of delayed gastric emptying after the pylorus-preserving PD when compared with the Frey procedure. The pooled data on delayed gastric emptying of all trials comparing DPPHR and PD for chronic pancreatitis surgery did not favor DPPHR (RR 0.23; P ϭ 0.07). However, analyzing the Frey procedures versus the pylorus-preserving PD, the meta-analysis indicated a significant superiority of the DPPHR (RR 0.06; P Ͻ0.01).
Patients who underwent DPPHR had significantly reduced durations of hospital stay (WMD Ϫ4.32 days; P Ͻ 0.01) which probably reflects the observed higher rates of overall morbidity in the PD groups. Moreover, we found significantly better results of DPPHR regarding weight gain (RR 1.93; P Ͻ 0.01), occupational rehabilitation (RR 1.36; P ϭ 0.01), and quality of life (WMD 25.07; P Ͻ 0.01) in comparison with PD. Thus, in addition to the short-term perioperative effects, the benefits of DPPHR seem to persist after a patient's discharge.
DPPHR was initially introduced in the treatment of chronic pancreatitis with the intention of reducing the post- operative impairment of endocrine pancreatic function. Although the long-term incidence of diabetes after the PD procedures have been reported in cohort studies as accounting for up to 48%, 42, 43 the preservation of the duodenum with its important function in glucose metabolism and the resection of less pancreatic tissue in DPPHR were expected to reduce these problems. However, none of the RCTs included report a significantly lower incidence of postoperative diabetes mellitus after DPPHR in comparison with PD procedures. [25] [26] [27] [28] Accordingly, the pooled results of these trials revealed no statistically significant benefit for the DPPHR (RR 0.49; P ϭ 0.08). However, data concerning postoperative new onset of exocrine insufficiency were available for 3 studies with the pooled results showing significant superiority of the DPPHR compared with the PD group (RR 0.20; P Ͻ 0.01). 26 -28 Our systematic literature search revealed a lack of studies comparing the various duodenum-preserving procedures in clearly defined study populations, highlighting the need for more well-designed RCTs analyzing the explicit techniques in this field. However, the results of our searches and analyses might be biased from several sides. First, our literature search could have failed to identify all relevant literature. However, the literature search was performed on several relevant databases including Medline, The Cochrane Library and Embase according to the standards of the Co- chrane Collaboration. Moreover, the selection of studies was done independently by 2 authors. Second, given that all relevant trials were identified, the underlying evidence might be too weak to draw any firm conclusions. In fact, the most common surgical interventions for the treatment of chronic pancreatitis were underpinned by single RCTs. Thus, the results of our study have to be interpreted with caution.
Third, our conclusions might be flawed because of the observed clinical and methodological heterogeneity of the individual trials.
There is evidence nonetheless for heterogeneity between the analyzed trials. Incomplete or nonexisting reporting of important design issues such as a description of the sample size calculation, the randomization process, and blinding impair the evaluation of trial quality. Besides methodology, clinical heterogeneity might also affect the results. Because the surgical procedures and the perioperative treatment were defined inappropriately in most reports, potential variations of surgical care may have influenced the results of this systematic review. Nevertheless, we consider our analyses to be relevant. As all trials were conducted in specialized centers by highly expertised surgeons, the standard of surgical care is likely to be similar among studies. Regarding methodological quality, comparable inaccuracies were observed in all included studies and there were no significant discrepancies in design between the analyzed trials. Despite all mentioned sources of heterogeneity, we still observed balanced groups when we compared interstudy baseline population characteristics. Finally, given the stable results we found when applying both the random and the fixed effects model for the statistical pooling, our calculations and assumptions are likely to be appropriate or even helpful for future decision making.
CONCLUSION
Our study provides the first quantitative comparison of DPPHR with PD. Although the results did not show any difference in terms of postoperative pain relief, overall morbidity, and the incidence of postoperative endocrine insufficiency, the presented findings suggest that DPPHR as the less invasive technique compared with PD has benefits in shortand long-term outcomes. However, our results should be interpreted cautiously because of potential sources of bias resulting from clinical and methodological heterogeneity in the underlying trials. To clearly prove superiority of DPPHR, trials of much higher sample size are needed. Based on the deficiencies of the RCTs assessed in this study, requested trials should be of higher methodological quality and reported in a standardized fashion. 35 
